Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study

QR Code

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study

Background-Several cardiovascular risk factors have been associated with the risk of atrial fibrillation (AF). Limited and inconsistent evidence exists on the association of blood lipid levels and lipid-lowering medication use with AF risk. Methods and Results-We analyzed 13 969 participants (25% Af...

Full description

Bibliographic Details
Main Authors:	Lopez, F., Agarwal, S., MacLehose, R., Soliman, E., Sharrett, A., Huxley, Rachel, Konety, S., Ballantyne, C., Alonso, A.
Format:	Journal Article
Published:	2012
Online Access:	http://hdl.handle.net/20.500.11937/39973

Similar Items

Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)

Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: The atherosclerosis risk in communities (ARIC) study
by: Huxley, Rachel, et al.
Published: (2011)

High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Filion, K., et al.
Published: (2011)

Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study
by: Huxley, Rachel, et al.
Published: (2013)

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)

High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study
by: Filion, K., et al.
Published: (2015)

Relation of serum phosphorus levels to the incidence of atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study)
by: Lopez, F., et al.
Published: (2013)

Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans: Atherosclerosis risk in communities (ARIC) study
by: Misialek, J., et al.
Published: (2013)

Carotid Intima-Media Thickness and Carotid Distensibility are Associated with Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Chen, L., et al.
Published: (2012)

Physical activity, obesity, weight change, and risk of atrial fibrillation the atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2014)

Birth weight and the risk of atrial fibrillation in whites and African Americans: The atherosclerosis risk in communities (ARIC) study
by: Lawani, S., et al.
Published: (2014)

Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study
by: Chen, L., et al.
Published: (2014)

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation
by: Huxley, Rachel, et al.
Published: (2011)

Atrial Fibrillation is Associated with Higher Risk of Dementia and Post-Dementia Hospitalization Mortality in Individuals Without Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
by: Chen, L., et al.
Published: (2011)

Lipid lowering effect of antioxidant alpha-lipoic acid in experimental atherosclerosis.
by: Amom, Zulkhairi, et al.
Published: (2008)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

Abdominal Obesity is an Independent Risk Factor for Sudden Cardiac Death in Non-Smoking Individuals: The Atherosclerosis Risk in Communities Study
by: Adabag, S., et al.
Published: (2013)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Troponin T, NT-proBNP, and Incidence of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
by: Folsom, A., et al.
Published: (2013)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study
by: Adabag, S., et al.
Published: (2015)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: The atherosclerosis risk in communities study
by: Folsom, A., et al.
Published: (2013)

Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)

Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)

Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)

Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern?
by: Saxena, A., et al.
Published: (2013)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)

Cannot write session to /tmp/vufind_sessions/sess_934v7vsrapmeo2kmksbleccog1